Estimating the Long Term Cost Savings from the Treatment of Alzheimer's Disease: A Modelling Approach

Author: Neumann P.J.

Source: PharmacoEconomics, Volume 17, Number 1, January 2000 , pp. 109-109(1)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $62.95 plus tax (Refund Policy)

Keywords: Alzheimer's disease, treatment; Anticholinesterases, therapeutic use; Clinical trial design; Cost analysis; Pharmacoeconomics; Rivastigmine, therapeutic use

Language: English

Document Type: Correspondence

Affiliations: 1: Harvard School of Public Health, Boston, Massachusetts, USA

Publication date: 2000-01-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page